Heilongjiang ZBD Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603567
  • 1d-2.00%
  • 1w-3.41%
  • 1m-2.62%
  • 1y-33.85%
ATH
  • ATH Price$50.10
  • ATH Date2015-05-27
  • % since ATH-78.50%
  • % to ATH365.18%
ATL
  • ATL Price$9.51
  • ATL Date2024-02-05
  • % from ATL13.25%
  • Last Low Price$9.51
  • Last Low Date2024-02-05
  • % From Last Low13.25%
IPO
  • IPO Price$28.32
  • % Current ROI USD-61.97%
  • ATH Price$50.10
  • % ROI ATH 52,681.07%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603567"]

Key Data [addtoany]

Current price $10.77
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $11.05/$10.64
Volume 1,941,038.00
Previous Close $10.99
52 Week High/Low $17.8387/$8.89
Market Cap 10,352,184,320.00
P/E Ratio 20.3519
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.77
Annualized Dividend $0.0025
$10.77
[addtoany]

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields.
The company was founded in 1996 and is based in Hulin, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity